CoChat

End-to-End Platform for Human Pluripotent Stem Cell Manufacturing

Open access
Pandey, Puspa R., Tomney, Amarel, Woon, Marites T., Uth, Nicholas, Shafighi, Farjad, Ngabo, Igor, Vallabhaneni, Haritha, Levinson, Yonatan, Abraham, Eytan, Friedrich Ben-Nun, Inbar · 2019 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Industrialization of stem-cell based therapies requires innovative solutions to close the gap between research and commercialization. Scalable cell production platforms are needed to reliably deliver the cell quantities needed during the various stages of development and commercial supply. Human pluripotent stem cells (hPSCs) are a key source material for generating therapeutic cell types. We have developed a closed, automated and scalable stirred tank bioreactor platform, capable of sustaining high fold expansion of hPSCs. Such a platform could facilitate the in-process monitoring and integration of online monitoring systems, leading to significantly reduced labor requirements and contamination risk. hPSCs are expanded in a controlled bioreactor using perfused xeno-free media. Cell harvest and concentration are performed in closed steps. The hPSCs can be cryopreserved to generate a bank of cells, or further processed as needed. Cryopreserved cells can be thawed into a two-dimensional (2D) tissue culture platform or a three-dimensional (3D) bioreactor to initiate a new expansion phase, or be differentiated to the clinically relevant cell type. The expanded hPSCs express hPSC-specific markers, have a normal karyotype and the ability to differentiate to the cells of the three germ layers. This end-to-end platform allows a large scale expansion of high quality hPSCs that can support the required cell demand for various clinical indications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21010089

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation of the end-to-end microcarrier-based human pluripotent stem cells (hPSCs) expansion platform. This platform includes the following attributes: perfused, xeno-free, proprietary media, plastic microcarriers (MCs) coated with proprietary matrix, high fold expansion without cell passaging, and a closed concentration step. The two-dimensional (2D) seed train could be avoided by using cryopreserved cells as the inoculum.
Figure 1 Schematic representation of the end-to-end microcarrier-based human pluripotent stem cells (hPSCs) expansion platform. This platform includes the following attributes: perfused, xeno-free, proprietary media, plastic microcarriers (MCs) coated with proprietary matrix, high fold expansion without cell passaging, and a closed concentration step. The two-dimensional (2D) seed train could be avoided by using cryopreserved cells as the inoculum.CC BY · PubMed Central
Figure 2 L7™ TFO2 hPSC xeno-free media supports the microcarrier (MC)-based expansion of RTiPSC3B and RTiPSC4i human-induced pluripotent stem cells (hiPSCs) leading to >2 × 106 cells/mL (A) and >10 fold expansion (B) in 17 days. Small- and large-sized MCs support the cell growth (C) and expansion (D) of RTiPSC3B in L7™ TFO2 hPSC xeno-free media. Inoculating less cells/mL does not compromise cell yield, but leads to rapid cell growth and higher cell expansion of RTiPSC4i (E,F) and RTiPSC3B (G,H), which were cultured on small- and large-sized MCs. Coating MCs with the L7™ hPSC Matrix is essential for the attachment and expansion of hiPSCs in L7™ TFO2 hPSC medium. RTiPSC3B inoculated at 0.2 × 106 cells/mL with small-sized microcarriers (I) and LiPSC18R inoculated at 0.04 × 106 cells/mL with large-sized microcarriers (J). RTiPSC4i inoculated at 0.04 × 106 cells/mL with large-sized coated and uncoated microcarriers. Cell growth (K) and fold expansion (L) are shown.
Figure 2 L7™ TFO2 hPSC xeno-free media supports the microcarrier (MC)-based expansion of RTiPSC3B and RTiPSC4i human-induced pluripotent stem cells (hiPSCs) leading to >2 × 106 cells/mL (A) and >10 fold expansion (B) in 17 days. Small- and large-sized MCs support the cell growth (C) and expansion (D) of RTiPSC3B in L7™ TFO2 hPSC xeno-free media. Inoculating less cells/mL does not compromise cell yield, but leads to rapid cell growth and higher cell expansion of RTiPSC4i (E,F) and RTiPSC3B (G,H), which were cultured on small- and large-sized MCs. Coating MCs with the L7™ hPSC Matrix is essential for the attachment and expansion of hiPSCs in L7™ TFO2 hPSC medium. RTiPSC3B inoculated at 0.2 × 106 cells/mL with small-sized microcarriers (I) and LiPSC18R inoculated at 0.04 × 106 cells/mL with large-sized microcarriers (J). RTiPSC4i inoculated at 0.04 × 106 cells/mL with large-sized coated and uncoated microcarriers. Cell growth (K) and fold expansion (L) are shown.CC BY · PubMed Central
Figure 3 Expansion of hiPSCs in 3 L bioreactor suspension cultures. (A) Consolidated cell density (left panel) and fold expansion (right panel) results from ten bioreactor runs using 2D-cultured RTiPSC3B, RTiPSC4i and LiPSC18R cell inoculum; (B) Representative images of cell-MC clusters on various days of the bioreactor run. Images are shown for RTiPSC3B, RTiPSC4i and LiPSC18R cell lines. Arrows indicate cells growing on MCs on the indicated days. Magnification, 100×; Scale bar: 200 µm.
Figure 3 Expansion of hiPSCs in 3 L bioreactor suspension cultures. (A) Consolidated cell density (left panel) and fold expansion (right panel) results from ten bioreactor runs using 2D-cultured RTiPSC3B, RTiPSC4i and LiPSC18R cell inoculum; (B) Representative images of cell-MC clusters on various days of the bioreactor run. Images are shown for RTiPSC3B, RTiPSC4i and LiPSC18R cell lines. Arrows indicate cells growing on MCs on the indicated days. Magnification, 100×; Scale bar: 200 µm.CC BY · PubMed Central
Figure 4 Monitoring of nutrient and metabolite concentrations and process parameters in 3 L bioreactor suspension cultures of hiPSCs. Offline monitoring of glucose consumption (A) and lactate production (B). Online monitoring of pH (C) and dissolved oxygen (DO) (D).
Figure 4 Monitoring of nutrient and metabolite concentrations and process parameters in 3 L bioreactor suspension cultures of hiPSCs. Offline monitoring of glucose consumption (A) and lactate production (B). Online monitoring of pH (C) and dissolved oxygen (DO) (D).CC BY · PubMed Central
Figure 5 Human iPSCs expanded in a bioreactor have typical hiPSC morphology and express hPSC-associated markers post-harvest. (A) Phase contrast images of iPSCs expanded in a bioreactor plated either as single cells after cell release from MCs (left panel), or as clusters of cells on MCs (right panel). Magnification, 100×; Scale bar: 100 µm; (B) Immunofluorescence staining of OCT3/4, NANOG, SSEA-4, TRA-1-60 and TRA-1-81 of iPSCs expanded in a bioreactor and plated onto 2D cell culture plates. Representative images from two different cell lines are shown. Magnification, 100×; (C) Quantitative analysis of hPSC-associated markers OCT3/4, SSEA4, TRA-1-60 and TRA-1-81 by flow cytometry of RTiPSC3B and LiPSC18R cells expanded in a bioreactor. Data obtained from either three independent runs (RTiPSC3B) or two independent runs (LiPSC18R). Data plotted are mean ± standard deviation (SD); (D) Pluripotency of RTiPSC3B cells expanded in a bioreactor demonstrated by embryoid body (EB) formation followed by immunofluorescence staining for germ layer-specific markers. Magnification, 100× (ectoderm, endoderm), 200× (mesoderm). (E) Representative immunofluorescence staining for lineage-specific markers RTiPSC3B and LiPSC18R cell lines. Magnification, 100× (Neural stem cells, definitive endoderm), 200× (cardiomyocytes)
Figure 5 Human iPSCs expanded in a bioreactor have typical hiPSC morphology and express hPSC-associated markers post-harvest. (A) Phase contrast images of iPSCs expanded in a bioreactor plated either as single cells after cell release from MCs (left panel), or as clusters of cells on MCs (right panel). Magnification, 100×; Scale bar: 100 µm; (B) Immunofluorescence staining of OCT3/4, NANOG, SSEA-4, TRA-1-60 and TRA-1-81 of iPSCs expanded in a bioreactor and plated onto 2D cell culture plates. Representative images from two different cell lines are shown. Magnification, 100×; (C) Quantitative analysis of hPSC-associated markers OCT3/4, SSEA4, TRA-1-60 and TRA-1-81 by flow cytometry of RTiPSC3B and LiPSC18R cells expanded in a bioreactor. Data obtained from either three independent runs (RTiPSC3B) or two independent runs (LiPSC18R). Data plotted are mean ± standard deviation (SD); (D) Pluripotency of RTiPSC3B cells expanded in a bioreactor demonstrated by embryoid body (EB) formation followed by immunofluorescence staining for germ layer-specific markers. Magnification, 100× (ectoderm, endoderm), 200× (mesoderm). (E) Representative immunofluorescence staining for lineage-specific markers RTiPSC3B and LiPSC18R cell lines. Magnification, 100× (Neural stem cells, definitive endoderm), 200× (cardiomyocytes)CC BY · PubMed Central
Figure 6 Concentrating hiPSCs by automated centrifugation. (A) Comparison of the viable cells which escape the kSep 400.50 chamber during the fluidized bed formation step. (B) Comparison of viable cells escaping the fluidized bed per kSep400 run versus the process time.
Figure 6 Concentrating hiPSCs by automated centrifugation. (A) Comparison of the viable cells which escape the kSep 400.50 chamber during the fluidized bed formation step. (B) Comparison of viable cells escaping the fluidized bed per kSep400 run versus the process time.CC BY · PubMed Central
Figure 7 Cells expanded in a bioreactor and concentrated by kSep show hPSC characteristics of morphology and marker expression. (A) Phase contrast images of single cells (RTiPSC3B and LiPSC18R) post concentration by kSep400, 24 h and 72 h post plating onto 2D cell culture plates. Magnification, 40×; (B) Immunofluorescence staining RTiPSC3B cells expanded in a bioreactor and concentrated via kSep show expression of OCT3/4, NANOG, SSEA-4 and TRA-1-60. Magnification, 100×; (C) Quantitative analysis of hPSC-associated markers SSEA4, TRA-1-60 and TRA-1-81 by flow cytometry of iPSCs expanded in a bioreactor and concentrated via kSep. Results are shown for RTiPSC3B and LiPSC18R lines; (D) Pluripotency of RTiPSC3B and LiPSC18R cells expanded in a bioreactor and concentrated by kSep were demonstrated by directed differentiation into definitive endoderm, neural stem cells and cardiomyocytes. Magnification, 100× (Neural stem cells, definitive endoderm), 200× (cardiomyocytes)
Figure 7 Cells expanded in a bioreactor and concentrated by kSep show hPSC characteristics of morphology and marker expression. (A) Phase contrast images of single cells (RTiPSC3B and LiPSC18R) post concentration by kSep400, 24 h and 72 h post plating onto 2D cell culture plates. Magnification, 40×; (B) Immunofluorescence staining RTiPSC3B cells expanded in a bioreactor and concentrated via kSep show expression of OCT3/4, NANOG, SSEA-4 and TRA-1-60. Magnification, 100×; (C) Quantitative analysis of hPSC-associated markers SSEA4, TRA-1-60 and TRA-1-81 by flow cytometry of iPSCs expanded in a bioreactor and concentrated via kSep. Results are shown for RTiPSC3B and LiPSC18R lines; (D) Pluripotency of RTiPSC3B and LiPSC18R cells expanded in a bioreactor and concentrated by kSep were demonstrated by directed differentiation into definitive endoderm, neural stem cells and cardiomyocytes. Magnification, 100× (Neural stem cells, definitive endoderm), 200× (cardiomyocytes)CC BY · PubMed Central
Figure 8 Quality of cryopreserved cells post thaw. (A) 6 × 105 cells from each vial were plated onto a well of a 6-well plate. Phase contrast images were taken 48–72 h post thaw. Magnification, 40×; (B) Cells were stained with AP staining kit three (vial #2) to five (all other vials) days post plating. Whole-well images are shown. Magnification, 1×.
Figure 8 Quality of cryopreserved cells post thaw. (A) 6 × 105 cells from each vial were plated onto a well of a 6-well plate. Phase contrast images were taken 48–72 h post thaw. Magnification, 40×; (B) Cells were stained with AP staining kit three (vial #2) to five (all other vials) days post plating. Whole-well images are shown. Magnification, 1×.CC BY · PubMed Central
Figure 9 iPSCs thawed directly into suspension show high fold expansion. (A) Cell growth (left panel) and fold expansion (right panel) of directly thawed vs. freshly inoculated LiPSC18R in spinner flasks; (B) Cell growth (left panel) and fold expansion (right panel) of LiPSC18R thawed into a 3 L bioreactor; (C) Phase contrast images demonstrating cell growth on MCs on different days of the bioreactor run. Arrows indicate cells growing on MCs on day 2. Magnification, 100×; Scale bar: 100 µm.
Figure 9 iPSCs thawed directly into suspension show high fold expansion. (A) Cell growth (left panel) and fold expansion (right panel) of directly thawed vs. freshly inoculated LiPSC18R in spinner flasks; (B) Cell growth (left panel) and fold expansion (right panel) of LiPSC18R thawed into a 3 L bioreactor; (C) Phase contrast images demonstrating cell growth on MCs on different days of the bioreactor run. Arrows indicate cells growing on MCs on day 2. Magnification, 100×; Scale bar: 100 µm.CC BY · PubMed Central
Figure 10 Thaw to 3D inoculation: iPSCs thawed into suspension retain hPSC-characteristics. (A) iPSCs thawed into suspension and expanded in a bioreactor have typical iPSC morphology when plated onto 2D, either before or after release from MCs. Magnification, 40×.; (B) Detection of hPSC-associated markers by immunofluorescence staining in cells post-harvest and concentration by kSep400. Magnification, 100×.; (C) Quantitative analysis of hPSC-associated markers by flow cytometry of cells post-harvest and cells concentrated after harvest; (D) Direct differentiation of iPSCs thawed into suspension, expanded in a bioreactor and concentrated via kSep400. Magnification, 100× (Neural stem cells, definitive endoderm), 200× (cardiomyocytes).2.13. D to 3D Inoculation.
Figure 10 Thaw to 3D inoculation: iPSCs thawed into suspension retain hPSC-characteristics. (A) iPSCs thawed into suspension and expanded in a bioreactor have typical iPSC morphology when plated onto 2D, either before or after release from MCs. Magnification, 40×.; (B) Detection of hPSC-associated markers by immunofluorescence staining in cells post-harvest and concentration by kSep400. Magnification, 100×.; (C) Quantitative analysis of hPSC-associated markers by flow cytometry of cells post-harvest and cells concentrated after harvest; (D) Direct differentiation of iPSCs thawed into suspension, expanded in a bioreactor and concentrated via kSep400. Magnification, 100× (Neural stem cells, definitive endoderm), 200× (cardiomyocytes).2.13. D to 3D Inoculation.CC BY · PubMed Central
Figure 11 Three dimensional (3D) to 3D inoculation. (A) Schematic representation of experimental design for using the 3D seed train as inoculum; (B) Cell growth (upper panel) and fold expansion (lower panel) of LiPSC18R on MCs collected from a spinner flask and inoculated in a 3 L bioreactor; (C) Cell growth (upper panel) and fold expansion (lower panel) of RTiPSC3B released from MCs as single cells and inoculated in a 3 L bioreactor; (D) Phase contrast images of LiPSC18R and RTiPSC3B cells growing on MCs on different days in 3D culture. Arrows indicate cells growing on microcarriers on day 2. Magnification, 100×; Scale bar: 200 µm; (E) Phase contrast images of colonies formed by cells expanded in a bioreactor. Cells were plated as cell–MC clusters. Images are shown for LiPSC18R cells (3D seed train by transferring cell–MC clusters) and RTiPSC3B (3D seed train by transferring single cells). Images were taken five days post plating. Magnification, 40×.
Figure 11 Three dimensional (3D) to 3D inoculation. (A) Schematic representation of experimental design for using the 3D seed train as inoculum; (B) Cell growth (upper panel) and fold expansion (lower panel) of LiPSC18R on MCs collected from a spinner flask and inoculated in a 3 L bioreactor; (C) Cell growth (upper panel) and fold expansion (lower panel) of RTiPSC3B released from MCs as single cells and inoculated in a 3 L bioreactor; (D) Phase contrast images of LiPSC18R and RTiPSC3B cells growing on MCs on different days in 3D culture. Arrows indicate cells growing on microcarriers on day 2. Magnification, 100×; Scale bar: 200 µm; (E) Phase contrast images of colonies formed by cells expanded in a bioreactor. Cells were plated as cell–MC clusters. Images are shown for LiPSC18R cells (3D seed train by transferring cell–MC clusters) and RTiPSC3B (3D seed train by transferring single cells). Images were taken five days post plating. Magnification, 40×.CC BY · PubMed Central
Figure 12 Quality assessment of hiPSCs expanded through a 3D seed train. (A) Immunofluorescence staining of hPSC-associated markers. Magnification, 100×; (B). Quantitative analysis of hPSC-associated markers; (C) Immunofluorescence staining of germ layer-specific markers, performed on embryoid bodies (EBs). Magnification, 100× (ectoderm, endoderm), 200× (mesoderm)
Figure 12 Quality assessment of hiPSCs expanded through a 3D seed train. (A) Immunofluorescence staining of hPSC-associated markers. Magnification, 100×; (B). Quantitative analysis of hPSC-associated markers; (C) Immunofluorescence staining of germ layer-specific markers, performed on embryoid bodies (EBs). Magnification, 100× (ectoderm, endoderm), 200× (mesoderm)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. Batalov, 2015, Differentiation of cardiomyocytes from human pluripotent stem cells using monolayer culture, Biomark. Insights, 10, 71

Cited by

See all 45

Metadata

Authors
Pandey, P. R., Tomney, A., Woon, M. T., Uth, N., Shafighi, F., Ngabo, I., Vallabhaneni, H., Levinson, Y., Abraham, E., & Friedrich Ben-Nun, I.
Affiliations
  • Lonza (United States) (US)
  • Cell and Gene Therapy Research and Development, Lonza Inc., Rockville, MD 20850, USA
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2019-12-21
Volume
21
Issue
1
Pages
89
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2995477520
Cited by
42
References
46
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 9 · 2021: 8 · 2020: 2 · 2019: 1
FWCI
1.66
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
human pluripotent stem cells, stem cell manufacturing, stirred tank bioreactor, cell cryopreservation, cell banking, stem cell differentiation, three germ layers, contamination risk reduction
MeSH terms
Cellular Reprogramming Techniques, Cell Differentiation, Cells, Cultured, Humans, Bioreactors, Myocytes, Cardiac, Cell Proliferation, Induced Pluripotent Stem Cells, Automation, Laboratory, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: End-to-End Platform for Human Pluripotent Stem Cell Manufacturing. https://app.cochat.ai/papers/10.3390/ijms21010089
The paper
Pandey, P. R., Tomney, A., Woon, M. T., Uth, N., Shafighi, F., Ngabo, I., Vallabhaneni, H., Levinson, Y., Abraham, E., & Friedrich Ben-Nun, I. (2019). End-to-End Platform for Human Pluripotent Stem Cell Manufacturing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21010089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.